Literature DB >> 36266566

Kelch-like proteins in the gastrointestinal tumors.

An-Bo Fu1,2,3, Sen-Feng Xiang4, Qiao-Jun He5,6, Mei-Dan Ying7,8.   

Abstract

Gastrointestinal tumors have become a worldwide health problem with high morbidity and poor clinical outcomes. Chemotherapy and surgery, the main treatment methods, are still far from meeting the treatment needs of patients, and targeted therapy is in urgent need of development. Recently, emerging evidence suggests that kelch-like (KLHL) proteins play essential roles in maintaining proteostasis and are involved in the progression of various cancers, functioning as adaptors in the E3 ligase complex and promoting the specific degradation of substrates. Therefore, KLHL proteins should be taken into consideration for targeted therapy strategy discovery. This review summarizes the current knowledge of KLHL proteins in gastrointestinal tumors and discusses the potential of KLHL proteins as potential drug targets and prognostic biomarkers.
© 2022. The Author(s), under exclusive licence to Shanghai Institute of Materia Medica, Chinese Academy of Sciences and Chinese Pharmacological Society.

Entities:  

Keywords:  KLHL; gastrointestinal tumors; prognostic biomarker; substrate; therapeutic target

Year:  2022        PMID: 36266566     DOI: 10.1038/s41401-022-01007-0

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   7.169


  104 in total

1.  Somatic mutations of the KEAP1 gene in common solid cancers.

Authors:  Nam Jin Yoo; Hyung Ran Kim; Yoo Ri Kim; Chang Hyeok An; Sug Hyung Lee
Journal:  Histopathology       Date:  2012-02-20       Impact factor: 5.087

2.  Inhibition of KLHL21 prevents cholangiocarcinoma progression through regulating cell proliferation and motility, arresting cell cycle and reducing Erk activation.

Authors:  Jian Chen; Wenfeng Song; Yehui Du; Zequn Li; Zefeng Xuan; Long Zhao; Jun Chen; Yongchao Zhao; Biguang Tuo; Shusen Zheng; Penghong Song
Journal:  Biochem Biophys Res Commun       Date:  2018-03-31       Impact factor: 3.575

Review 3.  Pancreatic cancer.

Authors:  Audrey Vincent; Joseph Herman; Rich Schulick; Ralph H Hruban; Michael Goggins
Journal:  Lancet       Date:  2011-05-26       Impact factor: 79.321

4.  Homozygous deletions at 3p22, 5p14, 6q15, and 9p21 result in aberrant expression of tumor suppressor genes in gastric cancer.

Authors:  Bona Lee; Kwiyeom Yoon; Sunghoon Lee; Jin Muk Kang; Junil Kim; Sung Han Shim; Hak-Min Kim; Sanghoon Song; Kazuhito Naka; An Keun Kim; Han-Kwang Yang; Seong-Jin Kim
Journal:  Genes Chromosomes Cancer       Date:  2014-12-17       Impact factor: 5.006

5.  Reliable Detection of Somatic Mutations in Fine Needle Aspirates of Pancreatic Cancer With Next-generation Sequencing: Implications for Surgical Management.

Authors:  Vicente Valero; Tyler J Saunders; Jin He; Matthew J Weiss; John L Cameron; Avani Dholakia; Aaron T Wild; Eun Ji Shin; Mouen A Khashab; Anne Marie O'Broin-Lennon; Syed Z Ali; Daniel Laheru; Ralph H Hruban; Christine A Iacobuzio-Donahue; Joseph M Herman; Christopher L Wolfgang
Journal:  Ann Surg       Date:  2016-01       Impact factor: 12.969

6.  Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer.

Authors:  Tatsuhiro Shibata; Akiko Kokubu; Masahiro Gotoh; Hidenori Ojima; Tsutomu Ohta; Masayuki Yamamoto; Setsuo Hirohashi
Journal:  Gastroenterology       Date:  2008-07-03       Impact factor: 22.682

7.  Methylation of the KEAP1 gene promoter region in human colorectal cancer.

Authors:  Naoyuki Hanada; Takenori Takahata; Qiliang Zhou; Xulu Ye; Ruowen Sun; Jugoh Itoh; Atsushi Ishiguro; Hiroshi Kijima; Junsei Mimura; Ken Itoh; Shinsaku Fukuda; Yasuo Saijo
Journal:  BMC Cancer       Date:  2012-02-13       Impact factor: 4.430

8.  Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets.

Authors:  Kornelius Schulze; Sandrine Imbeaud; Eric Letouzé; Ludmil B Alexandrov; Julien Calderaro; Sandra Rebouissou; Gabrielle Couchy; Clément Meiller; Jayendra Shinde; Frederic Soysouvanh; Anna-Line Calatayud; Roser Pinyol; Laura Pelletier; Charles Balabaud; Alexis Laurent; Jean-Frederic Blanc; Vincenzo Mazzaferro; Fabien Calvo; Augusto Villanueva; Jean-Charles Nault; Paulette Bioulac-Sage; Michael R Stratton; Josep M Llovet; Jessica Zucman-Rossi
Journal:  Nat Genet       Date:  2015-03-30       Impact factor: 38.330

9.  The 2019 WHO classification of tumours of the digestive system.

Authors:  Iris D Nagtegaal; Robert D Odze; David Klimstra; Valerie Paradis; Massimo Rugge; Peter Schirmacher; Kay M Washington; Fatima Carneiro; Ian A Cree
Journal:  Histopathology       Date:  2019-11-13       Impact factor: 5.087

10.  UHRF1 regulation of the Keap1-Nrf2 pathway in pancreatic cancer contributes to oncogenesis.

Authors:  Wafa Abu-Alainin; Thompson Gana; Triantafillos Liloglou; Adedamola Olayanju; Lawrence N Barrera; Robert Ferguson; Fiona Campbell; Timothy Andrews; Christopher Goldring; Neil Kitteringham; Brian K Park; Taoufik Nedjadi; Michael C Schmid; Joseph R Slupsky; William Greenhalf; John P Neoptolemos; Eithne Costello
Journal:  J Pathol       Date:  2015-11-30       Impact factor: 7.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.